ChromoGenics sees increasing market demand and has appointed Mats Hellman as Head of Business Development
ChromoGenics is accelerating its business and partner relationships given the increasing market demand for ConverLight™ dynamic glass and solar control. Mats Hellman has been appointed Head of Business Development. Mats brings vast experience from fast growing businesses and industrial expertise to ChromoGenics.
Mats has held several Vice President and General Management positions in Sweden and internationally establishing, driving and developing global businesses in multi culture environments.
“We are pleased to have Mats with us to drive our business development. Mats is entrepreneurial and has a long, broad and successful industrial experience, says Thomas Almesjö, CEO of ChromoGenics. “We are now in an exciting commercialization phase and with Mats and his extensive experience, we will accelerate our development of the business to new levels, including strategic partnerships, to strengthen ChromoGenics’ market position.”
ChromoGenics is currently ramping up production to meet the rapidly increasing market demand for ConverLight™ dynamic glass. The strengthened business development function will primarily reinforce the company’s sales and marketing activities.
"I'm excited to join ChromoGenics” says Mats. "ConverLight™ dynamic glass with its solar control is bringing significant sustainable value to buildings worldwide given the need for optimized energy efficiency and indoor comfort. I look forward to contribute to the future success of ChromoGenics, concludes Mats."
Contact:
Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communication
Tel: +46 18 430 0430
E-mail: info@chromogenics.com
About ChromoGenics
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com
Tags:
